Bennett Watson | Westwicke, Investor Relations |
Dan Barber | Chief Executive Officer |
Ernie Toth | Senior Vice President, Chief Financial Officer |
Steve Wargacki | Head of R&D |
Ken Truitt | Chief Medical Officer |
Ken Marshall | Chief Commercial Officer |
Francois Brisebois | Oppenheimer |
Thomas Flaten | Lake Street Capital Markets |
Ram Selvaraju | HC Wainwright |
James Malloy | Alliance Global Partners |
Good morning, and welcome to the Aquestive Therapeutics Fourth Quarter and Full Year 2022 Conference Call. At this time, all participants are in a listen only-mode. After the speakers' presentation, there will be a question-and-answer session. Instructions will be given at that time.
As a reminder, this call is being recorded.